Cipher Pharmaceuticals Inc (CPH) Scheduled to Post Quarterly Earnings on Friday

Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) will be announcing its earnings results before the market opens on Friday, November 3rd. Analysts expect the company to announce earnings of C$0.18 per share for the quarter.

Shares of Cipher Pharmaceuticals Inc (TSE CPH) opened at 4.33 on Wednesday. The stock’s market capitalization is $115.26 million. The company’s 50 day moving average is $4.53 and its 200-day moving average is $5.05. Cipher Pharmaceuticals Inc has a 52 week low of $3.50 and a 52 week high of $5.75.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at

Several analysts recently issued reports on the stock. TD Securities boosted their target price on shares of Cipher Pharmaceuticals from C$5.50 to C$6.50 in a research report on Monday, August 14th. Bloom Burton lowered shares of Cipher Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Monday, August 14th.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc, together with its subsidiaries, operates as a specialty pharmaceutical dermatology company in South America, Canada, and the United States. It offers CIP-ISOTRETINOIN, a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; CIP-FENOFIBRATE, a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and CIP-TRAMADOL ER, a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain.

What are top analysts saying about Cipher Pharmaceuticals Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cipher Pharmaceuticals Inc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit